Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-28

Clinical Trial Update: Microneedling and Latanoprost in Acrofacial Vitiligo [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on microneedling combined with latanoprost for vitiligo, across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

Sponsor: Sohag University | Conditions: Vitiligo | Phase 2, Phase 3 | Status: UNKNOWN